Approvedfor use through 11/30/2020. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no personsare required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Complete if Known
`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE EE
`STATEMENTBY APPLICANT Sauntfear
`(Use as many sheets as necessary) [ExaminerName__KATHRIEN ANN HARTSFIELD
`
`Attorney Docket Number
`46682-701.317
`
`16/908 426
`Application Number
`-22-
`Filing
`Dat
`
`
`U. S. PATENT DOCUMENTS
`
`Publication Date
`Nameof Patentee or
`Examiner
`Pages, Columns, Lines, Where
`Initials*
`MM-DD-YYYY
`Applicant of Cited Document
`Relevant Passages or Relevant
`Figures Appear
`
`.
`
`
`
`Document Number
`
`Number-Kind Code? “'ew)
`
`FOREIGN PATENT DOCUMENTS
`
`Examiner
`Initials*
`
`Cit
`le
`
`Foreign Patent Document
`
`Publication
`Date
`MM-DD-YYYY
`
`Nameof Patentee or
`Applicant of Cited Document
`
`Pages, Columns,Lines,
`WhereRelevant Passages
`Or Relevant Figures Appear
`
`Country Code*Number*Kind Code® (if known)
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Journal of Pharmacy 5(3-4):123-133 (1989).
`
`
`
`
`
`Examiner
`Initials*
`
`Include name of the author(in CAPITAL LETTERS),title of the article(when appropriate), title of
`the item (book, magazine,journal,serial,symposium,catalog,etc.),date, page(s), volume-issue
`number(s),publisher, city and/or country where published.
`
`
`;
`
`JIANG QIAOXI. Characteristics and Preparation of Dosage Forms of Ophthalmic Drugs. The
`
`002
`
`Shizhen WANG. Molecular Nuclear Medicine, Peking Union Medical College Press, the ist
`Edition, April 2004, p. 417, lines 9-10, published on April 30, 2004.
`
`Examiner
`Signature
`
`
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whetherornot citation is in conformance with MPEP 609. Drawline through citation if not in conformance and not
`considered. Include copy of this form with next communication to applicant. Applicant’s unique citation designation number (optional).
`; See Kinds Codes of USPTO Patent
`Documents at www.uspto.gov or MPEP 901.04. ° Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3). . For Japanese patent documents, the
`indication of the year of the reign of the Emperor must precede the serial number of the patent document. “kind of document by the appropriate symbols as indicated on the
`document under WIPO Standard ST.16 if possible. Applicant is to place a check mark here if English language Translation is attached. This collection of information is required by
`37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering, preparing, and submitting the completed application
`form to the USPTO. Timewill vary depending upon the individual case. Any comments on the amountof time you require to complete this form and/or suggestions for reducing this
`burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`

`

`Approvedfor use through 11/30/2020. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no personsare required to respond to a collection of information unlessit contains a valid OMB control number.
`
`Complete if Known
`Substitute for form 1449/PTO
`Application Number
`16/908426
`
`
`STATEMENTBY APPLICANT Sauntfear
`(Use as many sheets as necessary)
`|ExaminerName KATHRIEN ANN HARTSFIELD
`Attorney Docket Number
`46682-701.317
`
`Please see 37 CFR 1.97 and 1.98 to makethe appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`[]
`
`That eachitem of information contained in the information disclosure statement wasfirst cited in any
`communication from a foreign patentoffice in a counterpart foreign application not more than three monthsprior to
`the filing of the information disclosure statement. See 37 CFR 1.97(e)(1).
`
`That no item of information contained in the information disclosure statement wascited in a communication from a
`foreign patent office in a counterpart foreign application, and,
`to the knowledge of the person signing the
`certification after making reasonable inquiry, no item of information contained in the information disclosure
`statement was knownto any individual designated in 37 CFR 1.56(c) more than three monthsprior to the filing of
`the information disclosure statement. See 37 CFR 1.97(e)(2).
`
`See attached certification statement.
`
`Fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`DX] Acertification statement is not submitted herewith.
`
`SIGNATURE
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for
`the form of the signature.
`
`
`
`Signature
`
`/Erin A Boyle Anderson/
`
`Date (YYYY-MM-DD)
`
`Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit
`by the public whichis to file (and by the USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122
`and 37 CFR1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the
`completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the
`amountof time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief
`Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA
`22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for
`
`2023-12-19
`
`
`
`Name/Print 78136 Erin A. Boyle Anderson Registration Number
`
`
`
`
`
`

`

`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of
`the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be
`advised that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information
`solicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and TrademarkOffice
`is to process and/or examine your submission related to a patent application or patent. If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`resultin termination of proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom ofInformation Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Recordsfrom this system of records may be disclosed to the
`Departmentof Justice to determine whether disclosure of these recordsis required by the Freedom ofInformation
`Act.
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`A recordin this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request
`involving an individual, to whom the record pertains, when the individual has requested assistance from the Member
`with respect to the subject matter of the record.
`. Arecord in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need
`for the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization,
`pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposesof
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`. Arecord from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSAaspart of that agency's responsibility to
`recommend improvements in records managementpractices and programs, under authority of 44 U.S.C. 2904
`and 2906. Such disclosure shall be made in accordancewith the GSA regulations governing inspection of records
`for this purpose, and anyother relevant(.e., GSA or Commerce) directive. Such disclosure shall not be used to
`make determinations aboutindividuals.
`. Arecord from this system of records maybe disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record wasfiled
`in an application which became abandonedor in which the proceedings were terminated and which application is
`referenced byeither a published application, an application open to public inspection or an issued patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomesawareofa violation or potential violation of law or regulation.
`
`
`